Status:
COMPLETED
PET MRI Study in Patients With Cardiac Sarcoidosis
Lead Sponsor:
University Health Network, Toronto
Conditions:
Inflammatory Cardiomyopathy
Sarcoidosis
Eligibility:
All Genders
18+ years
Brief Summary
Myocarditis or inflammatory cardiomyopathy refers to inflammation of the heart muscle (the myocardium). Sarcoidosis is a multisystem granulomatous disorder that may involve the heart, causing inflamma...
Detailed Description
Myocarditis or inflammatory cardiomyopathy refers to inflammation of the myocardium. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology, which can result in myocardial inflammatio...
Eligibility Criteria
Inclusion
- The primary criterion for enrolment will be patients ≥18 years of age with known or suspected sarcoidosis or other inflammatory cardiomyopathy who are referred for clinically indicated 18F-FDG PET/CT imaging
Exclusion
- Standard cardiac MRI contraindications include arrhythmia, claustrophobia, history of allergic reaction or other contraindication to gadolinium-based contrast agent, impaired renal function with eGFR \< 60 ml/min/1.73m2, pregnancy, breast-feeding, or any other general contraindication to MRI (pacemaker, cerebral aneurysm clips, shrapnel, etc).
Key Trial Info
Start Date :
June 27 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 23 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03356756
Start Date
June 27 2016
End Date
February 23 2024
Last Update
May 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4